NL8600071A - Anti-psychotische, cyclische imidederivaten van 2-(4-butylpiperazine-1-yl)pyridines. - Google Patents

Anti-psychotische, cyclische imidederivaten van 2-(4-butylpiperazine-1-yl)pyridines. Download PDF

Info

Publication number
NL8600071A
NL8600071A NL8600071A NL8600071A NL8600071A NL 8600071 A NL8600071 A NL 8600071A NL 8600071 A NL8600071 A NL 8600071A NL 8600071 A NL8600071 A NL 8600071A NL 8600071 A NL8600071 A NL 8600071A
Authority
NL
Netherlands
Prior art keywords
piperazinyl
formula
butyl
pyridinyl
group
Prior art date
Application number
NL8600071A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8600071A publication Critical patent/NL8600071A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL8600071A 1985-01-16 1986-01-15 Anti-psychotische, cyclische imidederivaten van 2-(4-butylpiperazine-1-yl)pyridines. NL8600071A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69195285 1985-01-16
US06/691,952 US4619930A (en) 1985-01-16 1985-01-16 Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use

Publications (1)

Publication Number Publication Date
NL8600071A true NL8600071A (nl) 1986-08-18

Family

ID=24778661

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8600071A NL8600071A (nl) 1985-01-16 1986-01-15 Anti-psychotische, cyclische imidederivaten van 2-(4-butylpiperazine-1-yl)pyridines.

Country Status (29)

Country Link
US (1) US4619930A (zh)
JP (1) JPH0780873B2 (zh)
KR (1) KR900000366B1 (zh)
CN (1) CN1016691B (zh)
AT (1) AT391698B (zh)
AU (1) AU591473B2 (zh)
BE (1) BE904047A (zh)
CA (1) CA1284325C (zh)
CH (1) CH666269A5 (zh)
DE (1) DE3601143C2 (zh)
DK (1) DK19286A (zh)
EG (1) EG17759A (zh)
ES (2) ES8705869A1 (zh)
FI (1) FI90077C (zh)
FR (1) FR2580282B1 (zh)
GB (1) GB2191772B (zh)
HU (1) HU198202B (zh)
IE (1) IE58866B1 (zh)
IL (1) IL77577A (zh)
IT (1) IT1214497B (zh)
LU (1) LU86248A1 (zh)
NL (1) NL8600071A (zh)
NZ (1) NZ214790A (zh)
OA (1) OA08187A (zh)
PT (1) PT81843B (zh)
SE (1) SE466310B (zh)
SU (1) SU1521282A3 (zh)
YU (1) YU45757B (zh)
ZA (1) ZA859692B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4812567A (en) * 1985-10-16 1989-03-14 American Home Products Corporation Polycyclic spiroimides with psychotropic activity
MX174210B (es) * 1987-02-17 1994-04-28 Pfizer Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos
US4748240A (en) * 1987-04-03 1988-05-31 American Home Products Corporation Psychotropic bicyclic imides
DE3875073T2 (de) * 1987-11-20 1993-03-11 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
ES2084763T3 (es) * 1990-10-23 1996-05-16 Akzo Nobel Nv 4-(4- o 6-(2-trifluormetil piridinil))1-piperazinilalquilo lactamas sustituidas.
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
CN104230915B (zh) * 2014-08-29 2016-08-17 南京大学 含噻唑烷二酮的苯基哌嗪衍生物及其制备方法与用途
CN104513198A (zh) * 2014-11-29 2015-04-15 南京红太阳生物化学有限责任公司 一种2-氯烟酸的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
AT330777B (de) * 1973-09-08 1976-07-26 Thomae Gmbh Dr K Verfahren zur herstellung von neuen isochinolinderivaten und deren salzen
US4305944A (en) * 1980-09-08 1981-12-15 Mead Johnson & Company N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
DE3135532A1 (de) * 1981-09-08 1983-03-24 NPL po Dvigateli s Vatrešno Gorene, Varna Brennkraftmaschine
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
JPS61238784A (ja) * 1985-04-17 1986-10-24 Sumitomo Seiyaku Kk コハク酸イミド誘導体及びその酸付加塩
DE3529872A1 (de) * 1985-08-21 1987-02-26 Kali Chemie Pharma Gmbh Neue tetraoxoverbindungen

Also Published As

Publication number Publication date
FI90077B (fi) 1993-09-15
FI860136A (fi) 1986-07-17
GB8614686D0 (en) 1986-07-23
AU591473B2 (en) 1989-12-07
OA08187A (fr) 1987-10-30
FI860136A0 (fi) 1986-01-13
JPS61167682A (ja) 1986-07-29
ES557390A0 (es) 1988-02-16
IE58866B1 (en) 1993-11-17
IT8619081A0 (it) 1986-01-15
DK19286D0 (da) 1986-01-15
ATA10086A (de) 1990-05-15
CA1284325C (en) 1991-05-21
AU5229486A (en) 1986-07-24
KR860005808A (ko) 1986-08-13
ZA859692B (en) 1986-07-14
ES8801822A1 (es) 1988-02-16
DE3601143C2 (de) 1994-05-11
BE904047A (fr) 1986-07-15
SU1521282A3 (ru) 1989-11-07
US4619930A (en) 1986-10-28
IE860125L (en) 1986-07-16
GB2191772B (en) 1990-05-23
HUT39743A (en) 1986-10-29
YU4186A (en) 1987-10-31
AT391698B (de) 1990-11-12
PT81843B (pt) 1988-05-27
GB2191772A (en) 1987-12-23
ES8705869A1 (es) 1987-05-16
FR2580282B1 (fr) 1992-10-16
CH666269A5 (de) 1988-07-15
PT81843A (en) 1986-02-01
DK19286A (da) 1986-07-17
JPH0780873B2 (ja) 1995-08-30
SE466310B (sv) 1992-01-27
NZ214790A (en) 1989-04-26
YU45757B (sh) 1992-07-20
CN86100224A (zh) 1986-11-19
ES550829A0 (es) 1987-05-16
KR900000366B1 (ko) 1990-01-25
FI90077C (fi) 1993-12-27
DE3601143A1 (de) 1986-07-17
IL77577A (en) 1990-02-09
CN1016691B (zh) 1992-05-20
HU198202B (en) 1989-08-28
EG17759A (en) 1991-03-30
IT1214497B (it) 1990-01-18
LU86248A1 (fr) 1986-08-04
FR2580282A1 (fr) 1986-10-17
SE8600173L (sv) 1986-07-17
SE8600173D0 (sv) 1986-01-15

Similar Documents

Publication Publication Date Title
NL193283C (nl) 4,4-Dialkyl-1-[4-[4-(2-pirimidinyl)-1-piperazinyl]-butyl]-2,6- piperazinedionen.
JPH01249769A (ja) 向精神性ヘテロビシクロアルキルピペラジン誘導体
US20050165011A1 (en) Benzoxazine and benzoxazinone substituted triazoles
CA2480384A1 (en) Phenanthridinones as parp inhibitors
MXPA06000829A (es) 2-aminopirimidina y 2-aminopiridina-4-carbamatos en el tratamiento de enfermedades autoinmunes.
CS258119B2 (en) Method of 1-heteroaryl-4(2,5-pyrrolidione-1-yl)alkyl)piperazine derivatives production
JPH0517457A (ja) ベンズイソチアゾールおよびベンズイソキサゾールピペラジン誘導体
NL8600071A (nl) Anti-psychotische, cyclische imidederivaten van 2-(4-butylpiperazine-1-yl)pyridines.
NL8204974A (nl) 2-4-(4,4-dialkyl-2,6-piperidinedion-1-yl)butyl-1-piperazinylpyridines; een werkwijze voor het bereiden daarvan; hun toepassing in farmaceutische preparaten.
JPS59118782A (ja) ジヒドロピリジン類
US4757073A (en) Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use
Reddy et al. Water mediated one-pot and step-wise syntheses of indolylidine isoxazoles and their anti-cancer activity and molecular modeling studies
KR940000829B1 (ko) 항정신병성 융합-환의 피리디닐 피페라진 유도체의 제조방법
HU199124B (en) Process for producing benzazepine sulfonamides and antiarrhythmic agents comprising these compounds
US4677104A (en) Antipsychotic fused-ring pyridinylpiperazine derivatives
BG63305B1 (bg) Фармацевтични пиперазинови производни
JPH03106875A (ja) １―（３―ピリジルメチル）フタラジン誘導体
WO2008115259A2 (en) Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases
JPH0912562A (ja) 置換ベンゾチアジン誘導体
Karanik et al. Bicyclic aminoalkyl N-heterocycles by ring-chain-transformation of bridged 1, 3-dicarbonyl heteroanalogues with aminopyrazoles and aminotriazole
JPS59108783A (ja) アクリダノン誘導体
Borse Quinoline Based Heterocycles: Synthesis And Biological Activities
JPH03157384A (ja) 二環性トリアゾール誘導体
KR20070094949A (ko) 2-(시클릭 아미노카르보닐)인돌린 유도체 및 그것을함유하는 약제학적 조성물
川筋孝 Discovery of HIV-1 integrase inhibitors

Legal Events

Date Code Title Description
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable